Patent ID: 11963995
Assignee: FERRING B.V.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 8:
9. A method for reducing nocturnal urine volume in a female patient in need thereof, comprising:
measuring the patient's serum sodium level;
administering to the patient, with a serum sodium level of at least 130 mmol/L, prior to bedtime an orodispersible dose of desmopressin of 10 μg or 25 μg, wherein the dose is measured as the free base of desmopressin;
measuring the patient's serum sodium level at a time interval after administration;
continuing the administration of the dose of desmopressin over a treatment period if the female patient has a serum sodium level of at least 130 mmol/L;
wherein the dose administered over the treatment period reduces the patient's nocturnal urine volume.